open access

Vol 76, No 7 (2018)
Reviews
Published online: 2018-06-12
Submitted: 2018-06-12
Accepted: 2018-06-12
Get Citation

Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease

Artur Dziewierz, Dariusz Dudek
DOI: 10.5603/KP.a2018.0130
·
Kardiol Pol 2018;76(7):1043-1054.

open access

Vol 76, No 7 (2018)
Reviews
Published online: 2018-06-12
Submitted: 2018-06-12
Accepted: 2018-06-12

Abstract

New-generation drug-eluting stents are recommended as the default option in all clinical conditions and lesion subsets in patients undergoing percutaneous coronary intervention (PCI). On the other hand, despite achieving very good results in the rate of restenosis, permanent delivery of a metallic platform is affected by several drawbacks, such as caging of the vessel, side branch jailing, impairment of vasomotion, and the impossibility of lumen enlargement. Also, the presence of residual foreign material may increase the risk of late and very late stent thrombosis and support the need for long-term dual antiplatelet therapy after PCI. These pending limitations of metallic stents can be addressed by the implantation of bioresorbable scaf­folds (BRSs). At present, there are numerous devices available for preclinical or clinical evaluation. This review discusses the evidence for BRS in the management of patients with coronary artery disease.

Abstract

New-generation drug-eluting stents are recommended as the default option in all clinical conditions and lesion subsets in patients undergoing percutaneous coronary intervention (PCI). On the other hand, despite achieving very good results in the rate of restenosis, permanent delivery of a metallic platform is affected by several drawbacks, such as caging of the vessel, side branch jailing, impairment of vasomotion, and the impossibility of lumen enlargement. Also, the presence of residual foreign material may increase the risk of late and very late stent thrombosis and support the need for long-term dual antiplatelet therapy after PCI. These pending limitations of metallic stents can be addressed by the implantation of bioresorbable scaf­folds (BRSs). At present, there are numerous devices available for preclinical or clinical evaluation. This review discusses the evidence for BRS in the management of patients with coronary artery disease.

Get Citation

Keywords

bioresorbable scaffolds, scaffold thrombosis, stents, percutaneous coronary interventions, outcomes

About this article
Title

Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 76, No 7 (2018)

Pages

1043-1054

Published online

2018-06-12

DOI

10.5603/KP.a2018.0130

Bibliographic record

Kardiol Pol 2018;76(7):1043-1054.

Keywords

bioresorbable scaffolds
scaffold thrombosis
stents
percutaneous coronary interventions
outcomes

Authors

Artur Dziewierz
Dariusz Dudek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl